X
Snippet view
Table view
26 Results - per page
| Name |
Description |
Preferred ID |
Type |
ID |
Score | ||
|---|---|---|---|---|---|---|---|
| Recognition memory function | ILX:0109697 | term | ILX:0109697 | 313.24283 | Memory, Cognitive process, Behavioral process, Process, Processual entity, Occurrent | ||
| Executive function | A top-down system that manages and controls other cognitive processes, allowing goal-directed behavior. | CAO:00292 | term | ILX:0104013 | 209.86572 | Cognitive process, Behavioral process, Process, Processual entity, Occurrent | |
| Executive Function | A set of cognitive functions that controls complex, goal-directed thought and behavior. Executive function involves multiple domains, such as CONCEPT FORMATION, goal management, cognitive flexibility, INHIBITION control, and WORKING MEMORY. Impaired executive function is seen in a range of disorders, e.g., SCHIZOPHRENIA; and ADHD. | MESH:M0526990 | term | ILX:0737723 | 200.82721 | ||
| Free recall function | ILX:0104438 | term | ILX:0104438 | 195.7531 | Memory, Cognitive process, Behavioral process, Process, Processual entity, Occurrent | ||
| Requested recall function | ILX:0109942 | term | ILX:0109942 | 195.7531 | Memory, Cognitive process, Behavioral process, Process, Processual entity, Occurrent | ||
| Working memory | active maintenance and flexible updating of goal-task relevant information (items, goals, strategies, etc.) in a form that resists interference but has limited capacity. These representations may involve flexible binding of representations, may be characterized by the absence of external support for the internally maintained representations, and are frequently temporary due to ongoing interference | CAO:00587 | term | ILX:0112670 | 152.63203 | Memory, Cognitive process, Behavioral process, Process, Processual entity, Occurrent | |
| Wechsler Memory Scale | A neuropsychological test designed to assess different memory functions. It may incorporate an optional cognitive exam (Brief Cognitive Status Exam) that helps to assess memory related cognitive function. | MESH:M000620918 | term | ILX:0430174 | 136.13354 | ||
| Pattern Recognition | ILX:0108622 | term | ILX:0108622 | 16.75004 | Recognition memory function, Memory, Cognitive process, Behavioral process, Process, Processual entity, Occurrent | ||
| mh_mem2 (Cumulative Illness Rating Scale) | Memory problems (current impact) | NDA.CDE:2254257 | cde | CDE:0123816 | 11.34172 | Cumulative Illness Rating Scale, NIMH Data Archive Common Data Element | |
| updrs1 (Unified Parkinson's Disease Rating Scale) | I. Mentation, Behavior and Mood. Intellectual Impairment | NDA.CDE:2178662 | cde | CDE:0298254 | 9.64442 | Unified Parkinson's Disease Rating Scale, NIMH Data Archive Common Data Element | |
| Alzheimer disease | A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language. | MONDO:0004975 | term | ILX:0751626 | 9.388665 | Alzheimer disease, familial, Alzheimer's dementia, Alzheimers disease, AD, Alzheimers dementia, Alzheimer dementia, Alzheimer's disease, Alzheimer disease | |
| transient global amnesia (disease) | A condition characterized by sudden, temporary, usually short-lived memory loss, not associated with a neurologic disorder. Affected individuals lose memory function for recent events and have a decreased ability to retain new information. It is usually a solitary event. | MONDO:0001617 | term | ILX:0766815 | 8.107657 | transient global amnesia | |
| insomnia_interfere (Insomnia Severity Index) | To what extent do you consider your sleep problem to INTERFERE with your daily functioning (e.g. daytime fatigue, mood, ability to function at work/daily chores, concentration, memory, mood, etc.) CURRENTLY? PX640801_Insomnia_Interfere_DailyFunctioning | NDA.CDE:2190587 | cde | CDE:0166674 | 7.199586 | Insomnia Severity Index, NIMH Data Archive Common Data Element | |
| insomnia_interfere (PhenX Suicide Assessment) | To what extent do you consider your sleep problem to INTERFERE with your daily functioning (e.g. daytime fatigue, mood, ability to function at work/daily chores, concentration, memory, mood, etc.) CURRENTLY? PX640801_Insomnia_Interfere_DailyFunctioning | NDA.CDE:2120685 | cde | CDE:0250019 | 7.028988 | PhenX Suicide Assessment, NIMH Data Archive Common Data Element | |
| Cambridge neuropsychological test automated battery | is a computer-based cognitive assessment system consisting of a battery of neuropsychological tests, administered to subjects using a touch screen computer. The 22 tests in CANTAB examine various areas of cognitive function, including: * general memory and learning, * working memory and executive function, * visual memory, * attention and reaction time (RT), * semantic-verbal memory, * decision making and response control. The CANTAB endeavours to import the accuracy and rigour of computerised psychological testing whilst retaining the wide range of ability measures demanded of a neuropsychological battery. It is suitable for young and old subjects, and aims to be culture and language independent through the use of non-verbal stimuli in the majority of the tests. | CAO:00933 | term | ILX:0101613 | 6.773616 | Behavioral Experimental Paradigm, Experimental paradigm, Planned process, Process, Processual entity, Occurrent | |
| familial Alzheimer disease | A degenerative disease of the brain that causes gradual loss of memory, judgment, and the ability to function socially. About 25% of all Alzheimer disease is familial (more than 2 people in a family have AD). When Alzheimer disease begins before 60 or 65 years of age (early-onset AD) about 60% of the cases are familial (also known as Early-onset familial AD). These cases appear to be inherited in an autosomal dominant manner. | MONDO:0100087 | term | ILX:0766224 | 4.1235037 | Alzheimer disease, familial, FAD, GARD:0000632 | |
| fetal alcohol syndrome | Fetal alcohol syndrome (FAS) is a rare malformation syndrome caused by excessive maternal consumption of alcohol during pregnancy. It is characterized by prenatal and/or postnatal growth deficiency (weight and/or height <10th percentile), a unique cluster of minor facial anomalies (short palpebral fissures, flat and smooth philtrum, and thin upper lip) and severe central nervous system (CNS) abnormalities including microcephaly, and cognitive and behavioral impairment (intellectual disability, deficit in general cognition, learning and language, executive function, visual-spatial processing, memory, and attention). | MONDO:0016011 | term | ILX:0751646 | 3.650727 | static encephalopathy, alcohol-related birth defects, fetal alcohol spectrum disorders, FASD, ARND, ARBD, alcohol-related neurodevelopmental disorder, FAS | |
| Minaprine | Minaprine is a psychotropic drug which has proved to be effective in the treatment of various depressive states. Like most antidepressants minaprine antagonizes behavioral despair. Minaprine is an amino-phenylpyridazine antidepressant reported to be relatively free of cardiotoxicity, drowsiness, and weight gain. Pharmacology: Minaprine is an amino-phenylpyridazine antidepressant reported to be relatively free of cardiotoxicity, drowsiness, and weight gain. Similar to other antidepressant treatments, minaprine attenuates the beta-adrenergic receptor function. Studies have also shown that minaprine improves memory consolidation and that repeated drug administration leads to potentiation of this effect. Moreover, the effects of minaprine on memory consolidation are related to its dopaminergic action. Mechanism of action: Minaprine binds to serotonin type 2 receptors and to dopamine D1 and D2 type receptors. It also binds to the serotonin reuptake pump. Therefore, minaprine blocks the reuptake of both dopamine and serotonin. It is also, to a slight degree, cholinomimetic. Thus it may exhibit both mood-brightening and nootropic properties. Drug type: Approved. Small Molecule. Drug category: Antidepressive Agents. Antiparkinson Agents. Central Nervous System Agents | CHEBI:51038 | term | ILX:0106983 | 2.8021002 | Molecular entity, Material entity, Independent continuant, Continuant | Minaprina (INN-Spanish), Minaprine Dihydrochloride, Minaprine Hydrochloride, Minaprinum (INN-Latin), Brantur |
| Rivastigmine | Rivastigmine is a parasympathomimetic or cholinergic agent for the treatment of mild to moderate dementia of the Alzheimer s type. Rivastigmine is a cholinesterase inhibitor that inhibits both butyrylcholinesterase and acetylcholinesterase. Pharmacology: Rivastigmine is a parasympathomimetic and a reversible cholinesterase inhibitor. Rivastigmine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. Pathological changes in Dementia of the Alzheimer type involve cholinergic neuronal pathways that project from the basal forebrain to the cerebral cortex and hippocampus. These pathways are thought to be intricately involved in memory, attention, learning, and other cognitive processes. While the precise mechanism of rivastigmine's action is unknown, it is postulated to exert its therapeutic effect by enhancing cholinergic function. This is accomplished by increasing the concentration of acetylcholine through reversible inhibition of its hydrolysis by cholinesterase. If this proposed mechanism is correct, rivastigmine's effect may lessen as the disease process advances and fewer cholinergic neurons remain functionally intact. Mechanism of action: Rivastigmine increases the concentration of acetylcholine through reversible inhibition of its hydrolysis by cholinesterase. This acts to enhance cholinergic function. Drug type: Approved. Investigational. Small Molecule. Drug category: Cholinergic Agents. Cholinesterase Inhibitors. Neuroprotective Agents. Nootropic Agents. Parasympathomimetics | ILX:0110167 | term | ILX:0110167 | 2.6830504 | Molecular entity, Material entity, Independent continuant, Continuant | Ena 713 Free Base, Rivastigmine Hydrogen Tartrate, rivastigmine |
| Systems neuroscience | is a subdiscipline of neuroscience which studies the function of neural circuits and systems, most commonly in awake, behaving intact organisms. It is an umbrella term, encompassing a number of areas of study concerned with how nerve cells behave when connected together to form neural networks: vision, for example, or voluntary movement. At this level of analysis, neuroscientists study how different neural circuits analyze sensory information, form perceptions of the external worlds, make decisions, and execute movements. Researchers concerned with systems neuroscience focus on the vast space that exists between molecular and cellular approaches to the brain and the study of high-level mental functions such as language, memory, and self-awareness (which are the purview of behavioral and cognitive neuroscience). Systems neuroscientists typically employ techniques for understanding networks of neurons while they function in vivo (e.g. electrophysiology (single or multi-electrode recording), in vivo imaging, fMRI, PET). The term is commonly used in an educational framework: a common sequence of graduate school neuroscience courses consists of cellular/molecular neuroscience for the first semester, then systems neuroscience for the second semester. It is also sometimes used to distinguish a subdivision within a neuroscience department at an academic institution. - definition adapted from Wikipedia | NLXINV:100678 | term | ILX:0111436 | 2.5030184 | Scientific discipline, Generically dependent continuant, Dependent continuant, Continuant | Systems |
Preparing word cloud
About
The SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
Contact Us
FAIR Data Informatics Lab
University of California, San Diego
9500 Gilman Drive, Mail Code 0608
La Jolla, CA 92093-0608
United States
info 
scicrunch.org
scicrunch.orgX